Ayumo is a research and development company that provides deep learning services with medical insights and AI technology.
RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
QunaSys is a developer of software focused on algorithm and application development to advance the practical use of quantum technology. The company aims to harness quantum properties to create technologies that traditional methods cannot achieve. Its platform simulates phenomena related to the quantum mechanical behavior of electrons and atomic nuclei, facilitating the execution of quantum chemistry calculation algorithms on both quantum computers and simulators. By bridging the gap between theoretical quantum physics and practical applications, QunaSys seeks to bring quantum technologies to the forefront, enabling researchers to effectively explore and utilize these advanced capabilities.
A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.
Alpha Fusion specializes in the development of astatine-based radiopharmaceuticals for targeted alpha therapy, focusing on innovative cancer treatment solutions. The company is engaged in drug discovery and business development of low-molecular-weight and antibody-introduced astatine compounds. By harnessing alpha-ray nuclear medicine therapy, Alpha Fusion aims to provide healthcare providers with effective tools to combat cancer, enhancing treatment options for patients.
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Celaid Therapeutics focuses on the development and commercialization of regenerative medicine products that utilize human hematopoietic stem cells. The company specializes in cell therapy, leveraging advanced techniques for the expansion of these stem cells to create innovative medical solutions. In addition to its therapeutic offerings, Celaid Therapeutics also supports research and discovery by providing essential media reagents. This approach enables medical professionals to enhance hematopoietic stem cell transplantation and integrate gene-editing technology into their treatments, thereby advancing the field of regenerative medicine.
Developer of a healthcare technology designed to replace the traditional way of treating cancer treatment. The company aims to transform the traditional therapeutic into a next-generation therapy for cancer diseases by maximizing the drug potency with minimum toxicity, helping the healthcare sector to overcome systemic toxicity and exhibiting strong anti-tumor efficacy in various tumor models both as monotherapy and in combination with immune checkpoint inhibitors.
Restore Vision is a biotechnology company focused on developing innovative therapies for eye diseases, particularly retinitis pigmentosa. The company specializes in gene therapy, utilizing advanced technology to create therapeutic agents that address intractable eye conditions. Restore Vision's approach involves the use of chimeric rhodopsin genes, which enhance the functionality of conventional rhodopsins, allowing for increased sensitivity in patients. This technology aims to improve treatment outcomes for individuals suffering from various eye disorders, providing new hope for visual restoration.
Thinker provides sales of proximity sensors and proposed solutions using these products.
EX-Fusion is focused on developing and operating the world's first laser-powered commercial nuclear fusion reactor, aiming to provide sustainable energy solutions. The company specializes in manufacturing continuous plasma generators and offers technology for fusion systems, alongside conducting laser-plasma research. This initiative addresses the limitations of traditional government-funded fusion research, which often faces delays due to political and budgetary constraints. By pursuing an independent approach to fusion technology, EX-Fusion seeks to advance the practical application of laser fusion reactors, potentially revolutionizing the energy sector.
GAIA BioMedicine Inc. is a biopharmaceutical company based in Fukuoka Prefecture, Japan, founded in 2015 as a spin-off from Kyushu University. The company focuses on developing regenerative medicine products, specifically specializing in cell treatments and immunotherapies aimed at combating intractable malignancies. GAIA BioMedicine employs advanced technology to harness the power of genes and the immune system, enabling patients to better fight challenging diseases. With a commitment to innovation, the firm seeks to address significant unmet medical needs in cancer treatment through its specialized therapies.
GAIA BioMedicine Inc. is a biopharmaceutical company based in Fukuoka Prefecture, Japan, founded in 2015 as a spin-off from Kyushu University. The company focuses on developing regenerative medicine products, specifically specializing in cell treatments and immunotherapies aimed at combating intractable malignancies. GAIA BioMedicine employs advanced technology to harness the power of genes and the immune system, enabling patients to better fight challenging diseases. With a commitment to innovation, the firm seeks to address significant unmet medical needs in cancer treatment through its specialized therapies.
SK Fine is a pioneer in the field of 3D printing technology, being the first company in Japan to develop and market a 3D printer specifically for ceramics. The company specializes in producing ceramic parts that cannot be manufactured using traditional methods. By leveraging three-dimensional CAD data provided by clients, SK Fine creates customized ceramic components tailored to specific requirements. Additionally, the firm is advancing the development of 3D printing processes for various ceramic applications, allowing for greater flexibility and innovation in the production of ceramic parts. This focus on customization and technological advancement positions SK Fine as a leader in the ceramic 3D printing industry.
JiMED is a company specializing in wireless embedded brain-computer interface (BCI) systems that monitor brain activity. It offers a wireless implantable BCI system that utilizes an implanted device in conjunction with artificial intelligence to interpret brain signals. This innovative technology allows individuals with ALS to control the device through thought, significantly enhancing their ability to communicate and improve their quality of life.
Immunosens is a developer of electrochemical measurement devices that evaluate biomarkers, including genes, proteins, and cell signals, through electrode reactions. The company focuses on creating products that utilize disposable printable electrodes in their sensors, which enhances the accuracy of analyses and measurements. This technology is particularly beneficial for healthcare professionals in diagnosing medical conditions and conducting food safety inspections, ensuring reliable results in both domains.
HULIX Technologies specializes in developing and selling platforms for human flow space analysis. The company offers several services, including Human Navigation Research, which automatically gathers and visualizes human behavior data to identify unseen issues. Additionally, HULIX provides Hitonavi Cloud Basic, designed for conducting people flow surveys and verifications, and Hitonavi Cloud Advanced, which leverages collected data for applications in marketing, smart cities, security, and energy management. HULIX also focuses on creating a digital twin platform that enhances understanding of the real world for both humans and machines, promoting advancements in smart societal and industrial solutions while fostering a human-centered environment.
Aipore is a technology company specializing in the area of nanopore sensor using semiconductor Si microfabrication technology. The airpore technology is a collection of technological innovations such as Si MEMS, flow path surface control, multiphysics analysis, low noise amplification circuits, and sam concentration. It also uses AI to analyze this transient change in ion current to identify particles passing through the pore with high accuracy. Aipore was established in 2018 and is based in Shibuya-ku, Tokyo, Japan.
Cotobadeslgn is a dialogue content development company that develops a platform to interact with advanced AI technology.
Periotherapia is a drug discovery company focused on developing targeted medical treatments for intractable diseases, with a particular emphasis on triple negative breast cancer as its primary indication. The company aims to selectively inhibit specific disease-related pathways, notably the ASV involved in disease pathogenesis, while preserving the physiological functions of ASV in chronic conditions such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. By utilizing disease-specific antibodies, Periotherapia contributes to early diagnosis and precision medicine through companion diagnostics, thereby enhancing the ability of healthcare professionals to discover new therapeutic options for these challenging diseases.
GlyTech, Inc. specializes in the production of human-type N-glycans and the development of glycosylation technologies, including glycopeptide and glycoprotein synthesis. Founded in 2012 and based in Kyoto, Japan, the company focuses on enhancing the development of biopharmaceuticals and oligonucleotide therapeutics through innovative glycan production techniques. GlyTech offers a range of services, including custom synthesis, contract research and development, and the licensing of glycosylated peptides and proteins. Additionally, the company supplies standard reagents, supporting researchers in their efforts to advance human health by expanding their capabilities in glycoscience research and biotherapeutic analysis.
J-Pharma is a pharmaceutical company focused on developing novel drugs through a human-genomic approach, specifically targeting cell membrane transporters associated with various diseases. The company aims to create selective agents for treating conditions such as cancer by developing anti-cancer drugs and PET diagnostic agents that interact with transporters like LAT1, which are linked to cancer cell growth. J-Pharma's research emphasizes the importance of understanding drug transporters to enhance the pharmacokinetics of new drug candidates. By discovering key transporters within the human body, J-Pharma seeks to advance diagnostic methods and improve treatment options, thereby contributing to global health and enhancing the quality of life for aging populations in industrialized countries.
PGV Co., Ltd., established in September 2016 and headquartered in Japan, focuses on the development of advanced electroencephalograph (EEG) technology. The company specializes in creating a brain wave sensor device that allows for accurate measurement of brain waves, facilitating self-care and understanding of individual brain activity throughout various life stages. PGV aims to simplify EEG monitoring through its innovative patch-type electroencephalographs, making the process as straightforward as using a thermometer. By leveraging artificial intelligence for data analysis, PGV's technology supports both medical professionals in providing efficient patient care and individuals in managing their own brain health.
ThinkCyte, Inc. is a biotechnology company based in Tokyo, Japan, with an additional office in San Carlos, California. Founded in 2016, it specializes in developing an innovative cell sorting technology known as ghost cytometry, which leverages advanced optics and machine learning to perform high-throughput, image-free analysis and sorting of cells based on their morphology. This technology is designed for various applications in research, diagnostics, and therapeutics, facilitating single-cell analysis that is crucial for drug discovery, cell therapy, and clinical diagnostics. By enabling researchers to identify and isolate target cells, including rare cells, in real time, ThinkCyte aims to enhance the efficiency and accuracy of biological research and medical applications.
Kringle Pharma, Inc. is a biopharmaceutical company based in Ibaraki, Japan, founded in 2001. The company focuses on the research and development of hepatocyte growth factor (HGF) and its applications in treating various medical conditions. Kringle Pharma's HGF products aim to promote regenerative healing in liver cells and other organs, addressing acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scars. Additionally, the company develops NK4, a bi-functional molecule that serves as an HGF antagonist, inhibiting tumor cell invasion and metastasis while exhibiting antiangiogenic properties. Kringle Pharma's pipeline includes recombinant human HGF for acute renal failure and skin ulcers, as well as NK4-based therapies for cancer treatment.
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
PGV Co., Ltd., established in September 2016 and headquartered in Japan, focuses on the development of advanced electroencephalograph (EEG) technology. The company specializes in creating a brain wave sensor device that allows for accurate measurement of brain waves, facilitating self-care and understanding of individual brain activity throughout various life stages. PGV aims to simplify EEG monitoring through its innovative patch-type electroencephalographs, making the process as straightforward as using a thermometer. By leveraging artificial intelligence for data analysis, PGV's technology supports both medical professionals in providing efficient patient care and individuals in managing their own brain health.
Remohab Corporation, founded in 2017 and based in Suita City, Japan, specializes in remote telemedicine focused on rehabilitation, particularly for cardiac patients. The company has developed a system that utilizes ICT and IoT technologies to facilitate at-home cardiac rehabilitation. This innovative approach connects patients with healthcare professionals in remote medical institutions, allowing for continuous monitoring and support. The system provides a range of activity programs that patients can perform at home, enabling them to manage their health effectively while receiving guidance from nurses and healthcare providers.
mediVR is a Medical equipment which applies the video technology of Virtual Reality, etc. In Co., Ltd. mediVR, planning of the health care system, has been developing and sales.
Immunosens is a developer of electrochemical measurement devices that evaluate biomarkers, including genes, proteins, and cell signals, through electrode reactions. The company focuses on creating products that utilize disposable printable electrodes in their sensors, which enhances the accuracy of analyses and measurements. This technology is particularly beneficial for healthcare professionals in diagnosing medical conditions and conducting food safety inspections, ensuring reliable results in both domains.
Cykinso is a developer of a home-testing kit designed to tell people the state of their intestinal bacteria. The company provides a testing service to clarify the state of the intestinal environment by using a sequencer that reads a large number of DNA sequences at high speed, enabling users to investigate the relationship with lifestyle-related diseases and digestive diseases based on changes in intestinal bacteria.
MiCAN Technologies Inc. specializes in producing and supplying blood cell-like products for research purposes, utilizing advanced regenerative medicine technology. Founded in 2016 and based in Kyoto, Japan, the company focuses on developing new drugs for infectious diseases such as malaria and dengue. MiCAN offers specific products like MPV, a red blood-like cell designed for malaria research, and M02, a myeloid lineage cell suitable for dengue research. By providing homogeneous and stable experimental cells, MiCAN Technologies aims to streamline drug evaluation processes, enabling researchers and developers to discover new treatments for these diseases more efficiently and cost-effectively.
AI Samurai specializes in the development and sales of artificial intelligence technology. It also supports patent research and technical research. The company was founded in 2015.
Telenoid Healthcare Company Ltd., founded in 2015 and based in Tokyo, Japan, focuses on developing innovative solutions for elderly individuals with dementia. The company's flagship product, the Terenoid app, facilitates communication between dementia patients and their caregivers through a device equipped with a camera and microphone, allowing remote interaction. In addition to the Terenoid app, Telenoid offers the Chatter Box service, which provides a consulting platform for nursing care leaders, integrating a knowledge database that supports communication and enhances staff training. This service helps junior caregivers understand the perspectives of their senior counterparts by compiling personality data and insights from experienced staff. Telenoid's commitment to improving care for the elderly is reflected in its multi-disciplinary approach, which includes applications for research and educational institutions.
Periotherapia is a drug discovery company focused on developing targeted medical treatments for intractable diseases, with a particular emphasis on triple negative breast cancer as its primary indication. The company aims to selectively inhibit specific disease-related pathways, notably the ASV involved in disease pathogenesis, while preserving the physiological functions of ASV in chronic conditions such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. By utilizing disease-specific antibodies, Periotherapia contributes to early diagnosis and precision medicine through companion diagnostics, thereby enhancing the ability of healthcare professionals to discover new therapeutic options for these challenging diseases.
PaMeLa is a company that measures pain with science.PaMeLa will establish a method of objectively assessing pain and contribute to medical care.
ThinkCyte, Inc. is a biotechnology company based in Tokyo, Japan, with an additional office in San Carlos, California. Founded in 2016, it specializes in developing an innovative cell sorting technology known as ghost cytometry, which leverages advanced optics and machine learning to perform high-throughput, image-free analysis and sorting of cells based on their morphology. This technology is designed for various applications in research, diagnostics, and therapeutics, facilitating single-cell analysis that is crucial for drug discovery, cell therapy, and clinical diagnostics. By enabling researchers to identify and isolate target cells, including rare cells, in real time, ThinkCyte aims to enhance the efficiency and accuracy of biological research and medical applications.
C4U Co., Ltd. is a life science start-up based in Suita, Japan, founded in 2018. The company specializes in the research and development of genome editing technologies, particularly utilizing CRISPR and Cas3 methods. C4U aims to support drug discovery and develop new gene therapies for various intractable diseases. By applying its innovative technologies across multiple sectors, including medical, agricultural, forestry, livestock, and fishery, C4U seeks to address significant social issues.
SK Fine is a pioneer in the field of 3D printing technology, being the first company in Japan to develop and market a 3D printer specifically for ceramics. The company specializes in producing ceramic parts that cannot be manufactured using traditional methods. By leveraging three-dimensional CAD data provided by clients, SK Fine creates customized ceramic components tailored to specific requirements. Additionally, the firm is advancing the development of 3D printing processes for various ceramic applications, allowing for greater flexibility and innovation in the production of ceramic parts. This focus on customization and technological advancement positions SK Fine as a leader in the ceramic 3D printing industry.
Aipore is a technology company specializing in the area of nanopore sensor using semiconductor Si microfabrication technology. The airpore technology is a collection of technological innovations such as Si MEMS, flow path surface control, multiphysics analysis, low noise amplification circuits, and sam concentration. It also uses AI to analyze this transient change in ion current to identify particles passing through the pore with high accuracy. Aipore was established in 2018 and is based in Shibuya-ku, Tokyo, Japan.
Cotobadeslgn is a dialogue content development company that develops a platform to interact with advanced AI technology.
AI Samurai specializes in the development and sales of artificial intelligence technology. It also supports patent research and technical research. The company was founded in 2015.
NanoMist Technologies engages with R&D, design, and sells machines in the areas such as alcoholic beverages and food enrichment, fragrance extraction, chemical purification process, wastewater management, and deodorization process. NanoMist Technologies manufactures and sells machines such as ultrasonic atomization machine, deodorization machine, hot spring water concentration machine, solvent recovery machine, VOCs recovery machine, and granular material production machine.
C4U Co., Ltd. is a life science start-up based in Suita, Japan, founded in 2018. The company specializes in the research and development of genome editing technologies, particularly utilizing CRISPR and Cas3 methods. C4U aims to support drug discovery and develop new gene therapies for various intractable diseases. By applying its innovative technologies across multiple sectors, including medical, agricultural, forestry, livestock, and fishery, C4U seeks to address significant social issues.
MediTact is Contribute to the medical society through the challenging development of medical technologies that meet patient treatment needs.
ThinkCyte, Inc. is a biotechnology company based in Tokyo, Japan, with an additional office in San Carlos, California. Founded in 2016, it specializes in developing an innovative cell sorting technology known as ghost cytometry, which leverages advanced optics and machine learning to perform high-throughput, image-free analysis and sorting of cells based on their morphology. This technology is designed for various applications in research, diagnostics, and therapeutics, facilitating single-cell analysis that is crucial for drug discovery, cell therapy, and clinical diagnostics. By enabling researchers to identify and isolate target cells, including rare cells, in real time, ThinkCyte aims to enhance the efficiency and accuracy of biological research and medical applications.
Chromocenter Inc. is a biotechnology company based in Yonago, Japan, founded in 2005. The company specializes in developing artificial chromosome technologies primarily for applications in the life sciences and biopharmaceutical industries. Its innovations include the use of artificial chromosome vectors for drug discovery and the creation of stable gene expression cell lines, which facilitate high protein production. Chromocenter also engages in the production of transgenic animals and offers various chromosome analysis services, including multicolor FISH and mapping FISH. The organization's goal is to enhance the development of safe and effective medical pharmaceuticals, ultimately contributing to the treatment of various diseases.
Chromocenter Inc. is a biotechnology company based in Yonago, Japan, founded in 2005. The company specializes in developing artificial chromosome technologies primarily for applications in the life sciences and biopharmaceutical industries. Its innovations include the use of artificial chromosome vectors for drug discovery and the creation of stable gene expression cell lines, which facilitate high protein production. Chromocenter also engages in the production of transgenic animals and offers various chromosome analysis services, including multicolor FISH and mapping FISH. The organization's goal is to enhance the development of safe and effective medical pharmaceuticals, ultimately contributing to the treatment of various diseases.
Jeplan, Inc. is a Tokyo-based environmental firm that specializes in developing advanced recycling technologies and systems. Founded in January 2007, the company focuses on recycling various materials, including textiles and plastics. Jeplan employs proprietary technology to chemically recycle polyethylene terephthalate (PET) from waste food packaging, plastic bottles, and polyester fibers, producing recycled PET (r-PET) resin and Bis(2-Hydroxyethyl) terephthalate (r-BHET) resin. These materials are then utilized in the manufacture of new products, such as PET bottles and textiles. In addition to its recycling efforts, Jeplan promotes initiatives for the recycling of used uniforms and offers consulting services to businesses interested in adopting recycling practices.
GlyTech, Inc. specializes in the production of human-type N-glycans and the development of glycosylation technologies, including glycopeptide and glycoprotein synthesis. Founded in 2012 and based in Kyoto, Japan, the company focuses on enhancing the development of biopharmaceuticals and oligonucleotide therapeutics through innovative glycan production techniques. GlyTech offers a range of services, including custom synthesis, contract research and development, and the licensing of glycosylated peptides and proteins. Additionally, the company supplies standard reagents, supporting researchers in their efforts to advance human health by expanding their capabilities in glycoscience research and biotherapeutic analysis.
Immunosens is a developer of electrochemical measurement devices that evaluate biomarkers, including genes, proteins, and cell signals, through electrode reactions. The company focuses on creating products that utilize disposable printable electrodes in their sensors, which enhances the accuracy of analyses and measurements. This technology is particularly beneficial for healthcare professionals in diagnosing medical conditions and conducting food safety inspections, ensuring reliable results in both domains.
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
Pi-Crystal Incorporation, founded in 2013 and based in Osaka, Japan, specializes in the development and manufacturing of printable organic semiconductor integrated circuits. The company focuses on research, design, and sales of organic semiconductor materials and devices, as well as offering consulting services in organic semiconductor technology. Pi-Crystal’s innovative products are tailored for a wide range of industrial applications, utilizing unique materials and film formation methods distinct from traditional silicon semiconductors. This approach allows clients to produce flexible, lightweight, and cost-effective devices, thereby advancing technologies within the Internet of Things sector.
Periotherapia is a drug discovery company focused on developing targeted medical treatments for intractable diseases, with a particular emphasis on triple negative breast cancer as its primary indication. The company aims to selectively inhibit specific disease-related pathways, notably the ASV involved in disease pathogenesis, while preserving the physiological functions of ASV in chronic conditions such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. By utilizing disease-specific antibodies, Periotherapia contributes to early diagnosis and precision medicine through companion diagnostics, thereby enhancing the ability of healthcare professionals to discover new therapeutic options for these challenging diseases.
Elvez is a company focused on the research, development, and commercialization of dialogue technology aimed at addressing social issues through artificial intelligence. It offers a range of services, including a training management system, a WordPress plugin, and an AI-based consulting service accessible via smartphones and browsers. This enables seniors to utilize effective technology-driven consulting services. Elvez is dedicated to leveraging AI to create solutions that enhance communication and improve social interactions.
PGV Co., Ltd., established in September 2016 and headquartered in Japan, focuses on the development of advanced electroencephalograph (EEG) technology. The company specializes in creating a brain wave sensor device that allows for accurate measurement of brain waves, facilitating self-care and understanding of individual brain activity throughout various life stages. PGV aims to simplify EEG monitoring through its innovative patch-type electroencephalographs, making the process as straightforward as using a thermometer. By leveraging artificial intelligence for data analysis, PGV's technology supports both medical professionals in providing efficient patient care and individuals in managing their own brain health.
Remohab Corporation, founded in 2017 and based in Suita City, Japan, specializes in remote telemedicine focused on rehabilitation, particularly for cardiac patients. The company has developed a system that utilizes ICT and IoT technologies to facilitate at-home cardiac rehabilitation. This innovative approach connects patients with healthcare professionals in remote medical institutions, allowing for continuous monitoring and support. The system provides a range of activity programs that patients can perform at home, enabling them to manage their health effectively while receiving guidance from nurses and healthcare providers.
KOTAI Biotechnologies, Inc. is a biotechnology company based in Osaka, Japan, specializing in the development of a structural modeling and analysis platform for immune cell receptors. The platform utilizes advanced algorithms to analyze immune cell sequences and data derived from routine blood samples, providing insights into the structure and function of these receptors with remarkable precision. This technology has significant implications for understanding resistance to infections, autoimmune diseases, and cancer. KOTAI collaborates with universities, research institutions, and pharmaceutical companies to enhance the development of diagnostic and treatment methods. Their Repertoire Builder tool organizes receptors based on their target epitopes, employing both sequence and structural characteristics from B and T cell receptor models. This capability reveals the functional landscape of individual donors and quantifies variations among them, thereby facilitating drug discovery and improving diagnostic and prognostic outcomes.
Kyshow is a wholesaler that retails processed foods, fresh fish, and gift catalogs for midyear and year-end gifts.
Bioworks is a material creation company. They also provide raw material, polylactic acid, is derived from plants. Additionally, they also provide plant-derived biodegradable bioplastic and sustainable recycling-oriented products.
KOTAI Biotechnologies, Inc. is a biotechnology company based in Osaka, Japan, specializing in the development of a structural modeling and analysis platform for immune cell receptors. The platform utilizes advanced algorithms to analyze immune cell sequences and data derived from routine blood samples, providing insights into the structure and function of these receptors with remarkable precision. This technology has significant implications for understanding resistance to infections, autoimmune diseases, and cancer. KOTAI collaborates with universities, research institutions, and pharmaceutical companies to enhance the development of diagnostic and treatment methods. Their Repertoire Builder tool organizes receptors based on their target epitopes, employing both sequence and structural characteristics from B and T cell receptor models. This capability reveals the functional landscape of individual donors and quantifies variations among them, thereby facilitating drug discovery and improving diagnostic and prognostic outcomes.
PGV Co., Ltd., established in September 2016 and headquartered in Japan, focuses on the development of advanced electroencephalograph (EEG) technology. The company specializes in creating a brain wave sensor device that allows for accurate measurement of brain waves, facilitating self-care and understanding of individual brain activity throughout various life stages. PGV aims to simplify EEG monitoring through its innovative patch-type electroencephalographs, making the process as straightforward as using a thermometer. By leveraging artificial intelligence for data analysis, PGV's technology supports both medical professionals in providing efficient patient care and individuals in managing their own brain health.
KOTAI Biotechnologies, Inc. is a biotechnology company based in Osaka, Japan, specializing in the development of a structural modeling and analysis platform for immune cell receptors. The platform utilizes advanced algorithms to analyze immune cell sequences and data derived from routine blood samples, providing insights into the structure and function of these receptors with remarkable precision. This technology has significant implications for understanding resistance to infections, autoimmune diseases, and cancer. KOTAI collaborates with universities, research institutions, and pharmaceutical companies to enhance the development of diagnostic and treatment methods. Their Repertoire Builder tool organizes receptors based on their target epitopes, employing both sequence and structural characteristics from B and T cell receptor models. This capability reveals the functional landscape of individual donors and quantifies variations among them, thereby facilitating drug discovery and improving diagnostic and prognostic outcomes.
Chromocenter Inc. is a biotechnology company based in Yonago, Japan, founded in 2005. The company specializes in developing artificial chromosome technologies primarily for applications in the life sciences and biopharmaceutical industries. Its innovations include the use of artificial chromosome vectors for drug discovery and the creation of stable gene expression cell lines, which facilitate high protein production. Chromocenter also engages in the production of transgenic animals and offers various chromosome analysis services, including multicolor FISH and mapping FISH. The organization's goal is to enhance the development of safe and effective medical pharmaceuticals, ultimately contributing to the treatment of various diseases.
KDDD develop an innovative agent effective for various INCURABLE or INTRACTABLE eye diseases, especially CRAO, Retinal Pigmentosa, AMD and Glaucoma.
AFI Technology, established on December 23, 2013, in Seoul, Korea, specializes in manufacturing and selling innovative inspection and monitoring technology products primarily for the food and life science industries. The company offers electric filter separation technology and rapid detection systems that address microbial contamination risks, allowing clients to enhance food safety. With a strong emphasis on environmental responsibility, AFI responds to diverse needs in rapid microbiological testing and other technology solutions, underscoring its commitment to providing effective and efficient products for its clientele.
FunPep is a biotechnology company dedicated to the research and development of pharmaceuticals, cosmetics, and medical devices centered on functional peptides. The company specializes in creating treatments for intractable peptic ulcer disease, including antibody drugs and other pharmaceutical products. FunPep aims to innovate within the pharmaceutical sector by replacing traditional antibody medicines with next-generation products that utilize antibody-inducing peptides. Through its diverse portfolio, FunPep seeks to advance healthcare solutions and improve patient outcomes.
Matrixome is a nature, behavior, and fate of cells in a living body are determined by the interaction between cells and the extracellular environment, and is a coined word proposed by Professor Kiyotoshi Sekiguchi, Institute for Protein Research, Osaka University, as a concept that refers to the entire interaction.
JTEC Corporation, founded in 1993 and headquartered in Ibaraki, Japan, specializes in the design, manufacture, and sale of X-ray mirrors used in synchrotron facilities. These mirrors support research across various fields, including pharmaceuticals, electronics, materials, food, and beauty. In addition to X-ray mirrors, the company develops and produces automated cell culture systems and various automated systems for different applications. Its optical product lineup includes several types of mirrors, such as Kirkpatrick-Baez and deformable mirrors, as well as X-ray focusing alignment systems. JTEC Corporation's commitment to innovation and quality positions it as a key player in the fields of optics and life sciences.
Microwave Chemical is a company focused on the research and development of microwave technology. It specializes in engineering and licensing microwave processes tailored to specific product characteristics. The company offers comprehensive solutions that leverage its microwave platform technology, aiming to enhance efficiency and effectiveness in various applications.